A magnetically recoverable, fluorescence-tracked, molecularly imprinted nanocarrier for controlled bortezomib release

BACKGROUND: A dual fluorescent-magnetic molecularly imprinted nanocomposite (FMMIP-BTZ) was synthesized by coating Fe₃O₄ nanoparticles with silica and fluorescein-5-isothiocyanate, followed by in-situ polydopamine polymerization using bortezomib (BTZ) as template. METHODS: The prepared nanocomposite was characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), vibrating sample magnetometry (VSM), X-ray diffraction (XRD), fourier transform infrared (FTIR), UV-visible and fluorescence analysis. RESULTS: Template-selective recognition was confirmed by an imprinting factor of 3.20 (85.34 mg g⁻¹ for FMMIP versus 26.67 mg g⁻¹ for the non-imprinted control), with a BTZ loading efficiency of 69.3%. Release followed zero-order kinetics (k₀ = 3.276% h⁻¹, R² = 0.9937), reaching 80.5 ± 1% cumulative release, and was pH-responsive, rising from 41.1% at pH 7.4 to 84.5% at pH 4 over 6 h. Saturation magnetization fell from 0.48 to 0.04 emu g⁻¹ as the non-magnetic shell was added; despite this, particles remained separable under an external magnetic field at every synthesis, washing, and release step. Dual fluorescence from released BTZ and the FITC-labelled core enabled spectroscopic tracking of release. In an acute dermal irritation assessment, FMMIP-BTZ produced a mean erythema score of 1.00 at 24 h compared with 3.00 for the control. Molecular docking against COX-2, PRDX5, EGFR, and AKT1, together with a 100-ns MD simulation of the AKT1-bortezomib complex, provided exploratory mechanistic context for the experimentally observed response. CONCLUSION: FMMIP-BTZ is thus a molecularly selective, magnetically separable, fluorescence-trackable platform with controlled, pH-responsive release; cellular uptake, cytotoxicity, and in vivo antitumour efficacy remain to be established.

Authors

Institutions

Publication Details

Journal
Discover Nano
Published
2026-11-12
DOI
https://doi.org/10.1186/s11671-026-05039-x
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A magnetically recoverable, fluorescence-tracked, molecularly imprinted nanocarrier for controlled bortezomib release

Mehwish Raza, Taha Majid Mahmood Sheikh, Zeeshan Ali, Muhammad Hayat et al.
Discover Nano
Nanoparticle-Based Drug Delivery
article

A magnetically recoverable, fluorescence-tracked, molecularly imprinted nanocarrier for controlled bortezomib release

Mehwish Raza, Taha Majid Mahmood Sheikh, Zeeshan Ali, Muhammad Hayat, Hafiz Muhmmad Usman Abid
article en

Abstract

BACKGROUND: A dual fluorescent-magnetic molecularly imprinted nanocomposite (FMMIP-BTZ) was synthesized by coating Fe₃O₄ nanoparticles with silica and fluorescein-5-isothiocyanate, followed by in-situ polydopamine polymerization using bortezomib (BTZ) as template. METHODS: The prepared nanocomposite was characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), vibrating sample magnetometry (VSM), X-ray diffraction (XRD), fourier transform infrared (FTIR), UV-visible and fluorescence analysis. RESULTS: Template-selective recognition was confirmed by an imprinting factor of 3.20 (85.34 mg g⁻¹ for FMMIP versus 26.67 mg g⁻¹ for the non-imprinted control), with a BTZ loading efficiency of 69.3%. Release followed zero-order kinetics (k₀ = 3.276% h⁻¹, R² = 0.9937), reaching 80.5 ± 1% cumulative release, and was pH-responsive, rising from 41.1% at pH 7.4 to 84.5% at pH 4 over 6 h. Saturation magnetization fell from 0.48 to 0.04 emu g⁻¹ as the non-magnetic shell was added; despite this, particles remained separable under an external magnetic field at every synthesis, washing, and release step. Dual fluorescence from released BTZ and the FITC-labelled core enabled spectroscopic tracking of release. In an acute dermal irritation assessment, FMMIP-BTZ produced a mean erythema score of 1.00 at 24 h compared with 3.00 for the control. Molecular docking against COX-2, PRDX5, EGFR, and AKT1, together with a 100-ns MD simulation of the AKT1-bortezomib complex, provided exploratory mechanistic context for the experimentally observed response. CONCLUSION: FMMIP-BTZ is thus a molecularly selective, magnetically separable, fluorescence-trackable platform with controlled, pH-responsive release; cellular uptake, cytotoxicity, and in vivo antitumour efficacy remain to be established.

Discover NanoVol. 21(1)
Bahauddin Zakariya University (PK), Shandong Xiehe University (CN), NFC Institute of Engineering and Technology (PK), Bahria University (PK)
Bahauddin Zakariya University
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon